Dr Boreham's Crucible: Race Oncology
Race Oncology tells a story all too familiar among developing Aussie biotechs, Tim Boreham reports
Stay updated with breaking news from Daniel Tillett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Race Oncology tells a story all too familiar among developing Aussie biotechs, Tim Boreham reports
Race Oncology Ltd (ASX:RAC) executive director Pete Smith speaks with Proactive alongside the company’s recently appointed CEO - 25-year veteran of the...
The ASX is set to open lower this morning — the ASX futures are down 6 points, or 0.1%, at 7,099 at 8.45am AEDT. The focus today is on the RBA, with...
Race Oncology Ltd (ASX:RAC) has appointed a 25-year veteran of the biotech space, Dr Daniel Tillett, as CEO, effective today. In this pivotal role,...
Cancer remains one of the most pressing public health challenges worldwide, affecting millions of lives and compounding economic burdens along the way. ...